Nucleocytosis: Japanese Researchers Name a Previously Unknown Way Immune Cells Harvest DNA from Dying Neighbors

Cell biology has accumulated, over decades of careful observation, a fairly detailed inventory of how cells interact with each other and with their own contents. The nucleus - sealed behind a double membrane, guarded by nuclear pore complexes - was considered largely inaccessible to neighboring cells except under exceptional circumstances: during cell division, when the nuclear envelope temporarily dissolves, or during cell death, when structures break down entirely.

That picture may need revision.

A research team at the University of Tokyo has identified a cellular process that does not fit any known category. In experiments examining how immune cells respond to dying neighbors, they observed something unexpected: immune cells were selectively extracting nuclear DNA from dying cells in a controlled, repeatable manner - without triggering classical breakdown of the nuclear envelope and without consuming the dying cell entirely through phagocytosis. The process was distinct enough from anything previously described that the team assigned it a new name: nucleocytosis.

The findings were published in Nature Communications on February 18, 2026, led by Professor Ken J. Ishii from the Department of Microbiology and Immunology at the Institute of Medical Science, along with Dr. Hideo Negishi, Mr. Yusuke Wada, and Dr. Yoshitaka Shirasaki from the Research Center for Advanced Science and Technology.

What Nucleocytosis Looks Like Under the Microscope

Using advanced imaging techniques alongside experimental immune cell models, the researchers tracked the movement of nuclear components during interactions between immune cells and dying cells under specific stimulation conditions. Rather than observing passive nuclear content leakage or full cellular engulfment, they found something more precise: nuclear DNA was being selectively accessed and removed from the nuclei of dying cells, while the nuclear envelope itself remained largely intact.

"The most striking aspect of our findings was realizing that cells possess an entirely new way to handle nuclear contents," Professor Ishii noted in describing the work.

The process appeared consistently across multiple experimental conditions, suggesting it represents a genuine and regulated cellular function rather than a laboratory artifact. Subsequent experiments confirmed that nucleocytosis is not random - it appears to be triggered under specific circumstances involving immune cell-dying cell contact, and the extracted nuclear DNA may serve as a molecular signal rather than simply being degraded.

Why Would Immune Cells Want Nuclear DNA from Dying Neighbors?

This is the question that makes nucleocytosis potentially significant beyond its novelty as a cellular curiosity. DNA released from dying cells is not biologically inert. The immune system uses DNA - particularly its structural patterns and the presence of certain sequences - as a damage signal. Cytosolic DNA sensing pathways, including the cGAS-STING system, detect the presence of DNA in places it shouldn't be and trigger inflammatory responses accordingly.

If immune cells are actively extracting nuclear DNA from dying neighbors, rather than simply waiting for it to leak out passively, that active extraction process could represent a previously unrecognized mechanism for initiating or modulating immune signaling. The dying cell's DNA, selectively harvested, might serve as a directed communication - alerting the immune system to the nature of the cell death, shaping inflammatory responses in ways that differ from passive DNA release.

The researchers suggest that nucleocytosis could be a mechanism by which immune cells sample the genetic status of dying cells - potentially detecting viral infection, oncogenic mutations, or other DNA-level pathologies before the dying cell disintegrates entirely.

Limitations and Open Questions

This research is in its early stages. The experiments were conducted in laboratory cell culture systems, and whether nucleocytosis occurs in living organisms at physiologically relevant rates remains to be established. The study identifies the phenomenon and characterizes some of its features, but the molecular machinery responsible - what proteins on the immune cell surface initiate the extraction, what directs the process toward nuclear rather than cytoplasmic contents - has not yet been fully described.

Importantly, the downstream consequences of nucleocytosis are not yet known. Does the extracted DNA trigger specific immune pathways? Does it influence the type or magnitude of inflammatory response? Does it happen in the context of cancer, infection, or autoimmune disease in ways that matter clinically? These questions define the research agenda that this discovery opens up.

The classification of nucleocytosis as a new cellular mechanism is itself a significant act in biology - naming something implies a coherent, describable process that differs sufficiently from existing categories to warrant its own identity. That the authors felt confident enough to assign a name suggests the process has features that are clearly distinguishable from phagocytosis, trogocytosis (partial membrane transfer between cells), and other known forms of intercellular material exchange.

If nucleocytosis holds up under further scrutiny, it adds a new operation to the cellular repertoire - one that suggests immune cells are more active, and more targeted, in how they gather information from dying neighbors than previously appreciated.